Shares of Insperity (NSP), a leading human resources and business performance solutions provider, plummeted 5.51% in pre-market trading on Friday following the release of its disappointing second-quarter earnings report and lowered full-year guidance.
The company reported adjusted earnings per share (EPS) of $0.26 for the quarter ended June 30, significantly below the analyst consensus estimate of $0.43 and down from $0.86 in the same period last year. Revenue for the quarter came in at $1.658 billion, slightly missing the expected $1.662 billion but showing a 3% increase from the previous year.
Insperity's performance was impacted by higher-than-expected benefits costs, primarily driven by elevated pharmacy trends and large claim activities. This resulted in a decrease in gross profit from $260 million in Q2 2024 to $223 million in Q2 2025. Adding to investors' concerns, the company lowered its full-year 2025 adjusted EPS guidance to a range of $1.81 to $2.51, down from the previous outlook of $2.23 to $3.28. This reduction in guidance, coupled with the earnings miss, likely contributed to the sharp decline in the stock price.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.